학술논문
Effects of Pain, Insomnia, and Depression on Psychoactive Medication Supply in Older Adults With Osteoarthritis
Document Type
research-article
Author
Source
Medical Care, 2018 Dec 01. 56(12), 1024-1031.
Subject
Language
English
ISSN
00257079
15371948
15371948
Abstract
Determinants of prescribing psychoactive medications for symptom management in older adults remain underexamined despite known risks and cautions concerning these medications.
To examine independent and combined effects of pain, concurrent insomnia and depression symptoms on psychoactive medications supplied to older adults with osteoarthritis (OA).
Survey data on pain, insomnia, and depression obtained from OA patients screened for a randomized controlled trial were used to identify predictors of psychoactive medication supply [opioids, sedatives, tricyclic antidepressants (TCAs), and non-TCAs] over a 4-year period.
Group Health Cooperative patients with a diagnosis of OA (N = 2976).
Survey data on pain (Graded Chronic Pain Scale), insomnia (Insomnia Severity Index), and depression (Patient Health Questionnaire-8); and medications supply assessed from electronic medical records.
In negative binomial models, pain [incidence rate ratio (IRR), 2.8–3.5; P < 0.001], insomnia (IRR, 2.0; P < 0.001), and depression (IRR, 1.5; P < 0.05) each independently predicted opioid supply. Insomnia (IRR, 3.2; P < 0.001) and depression (IRR, 3.0; P < 0.001) each independently predicted sedative supply. Pain (IRR, 2.1; P < 0.05) and insomnia (IRR, 2.0; P < 0.05) independently predicted TCA supply, whereas only depression (IRR, 2.2; P < 0.001) independently predicted non-TCA supply. Combined effects of pain and insomnia/depression on these medications were additive and increased the rate of medication supply 1.5–7.5 times. Combined effects increased with insomnia or depression severity.
Concurrent insomnia and depressive symptoms predicted increased supply of opioids, sedatives, and antidepressants after accounting for pain, indicating the importance of sleep and mood disorders as factors increasing supply of these medications.
To examine independent and combined effects of pain, concurrent insomnia and depression symptoms on psychoactive medications supplied to older adults with osteoarthritis (OA).
Survey data on pain, insomnia, and depression obtained from OA patients screened for a randomized controlled trial were used to identify predictors of psychoactive medication supply [opioids, sedatives, tricyclic antidepressants (TCAs), and non-TCAs] over a 4-year period.
Group Health Cooperative patients with a diagnosis of OA (N = 2976).
Survey data on pain (Graded Chronic Pain Scale), insomnia (Insomnia Severity Index), and depression (Patient Health Questionnaire-8); and medications supply assessed from electronic medical records.
In negative binomial models, pain [incidence rate ratio (IRR), 2.8–3.5; P < 0.001], insomnia (IRR, 2.0; P < 0.001), and depression (IRR, 1.5; P < 0.05) each independently predicted opioid supply. Insomnia (IRR, 3.2; P < 0.001) and depression (IRR, 3.0; P < 0.001) each independently predicted sedative supply. Pain (IRR, 2.1; P < 0.05) and insomnia (IRR, 2.0; P < 0.05) independently predicted TCA supply, whereas only depression (IRR, 2.2; P < 0.001) independently predicted non-TCA supply. Combined effects of pain and insomnia/depression on these medications were additive and increased the rate of medication supply 1.5–7.5 times. Combined effects increased with insomnia or depression severity.
Concurrent insomnia and depressive symptoms predicted increased supply of opioids, sedatives, and antidepressants after accounting for pain, indicating the importance of sleep and mood disorders as factors increasing supply of these medications.